NTRA Q3 2021 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q3 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$158M+61.1% YoY

Gross Profit

$77M48.5% margin

Operating Income

-$150M-95.0% margin

Net Income

-$151M-95.7% margin

EPS (Diluted)

$-1.63

QoQ Revenue Growth

+11.3%

Cash Flow

Operating Cash Flow

-$91M

Free Cash Flow

-$104M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$552M

Stockholders' Equity

$759M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$158M	$98M	+61.1%
Gross Profit	$77M	$46M	+65.7%
Operating Income	-$150M	-$56M	-169.3%
Net Income	-$151M	-$58M	-159.4%

Revenue Segments

Product

$151M95%

Licensing And Other

$7M5%

Geographic Segments

U

$148M94%

E M E A

$6M4%

Other Geographic Areas

$3M2%

Americas Excluding Us

$1M1%